more

Walgreens Boots Alliance (WBA)

(Real Time Quote from BATS)

$11.32 USD

-0.44 (-3.74%)

Updated Jan 13, 2025 11:44 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.35%
2	Buy	18.11%
3	Hold	9.74%
4	Sell	5.34%
5	Strong Sell	2.80%
S&P	500	11.41%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5 4

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth F Momentum B VGM

Industry Rank:

Bottom 4% (241 out of 250)

Industry: Retail - Pharmacies and Drug Stores

View All Zacks #1 Ranked Stocks

Research for WBA

Annual Key Company Metrics
Quarterly Key Company Metrics

Revenue - Line of Business Segments	YR Estimate	08/31/2024	08/31/2023	08/31/2022	08/31/2021	08/31/2020
Revenues: U.S. Retail Pharmacy [$...	--	124,176	116,883	110,873	112,005	107,701
Revenues: U.S. Healthcare [$M]	--	8,345	6,570	1,795	--	--
Revenues: U.S. Retail Pharmacy: P...	--	88,867	82,118	80,434	84,892	80,481
Revenues: U.S. Retail Pharmacy: R...	--	26,911	28,195	28,643	27,113	27,220
Revenues: International - Pharmac...	--	3,598	3,664	3,727	3,808	3,503
Revenues: International - Retail ...	--	7,887	7,324	6,924	6,225	5,902
Revenues: International - Wholesa...	--	12,067	11,211	11,178	10,472	4,876
Income - Line of Business	YR Estimate	08/31/2024	08/31/2023	08/31/2022	08/31/2021	08/31/2020
Adjusted operating income (loss):...	--	2,167	3,689	5,029	5,019	4,761
Adjusted operating income (loss):...	--	793	935	726	466	157
Adjusted operating income (loss):...	--	-134	-566	-370	-57	--
Adjusted operating income (loss):...	--	-202	-187	-251	-311	-187
Operating Income (GAAP): U.S. Ret...	--	-385	-5,307	2,907	2,554	3,312
Operating Income (GAAP): Internat...	--	682	379	-346	227	-2,090
Operating Income (GAAP): U.S. Hea...	--	-14,241	-1,725	-829	-57	--
Operating Income (GAAP): Corporat...	--	-133	-228	-345	-382	-239
NFM - Operating & Non Financial Metrics	YR Estimate	08/31/2024	08/31/2023	08/31/2022	08/31/2021	08/31/2020
Comparable sales - U.S. Retail Ph...	--	10	7	5	--	--
30-day equivalent prescriptions [...	--	1,226	1,212	1,216	--	--
Number of locations - Total U.S. ...	--	8,572	8,720	8,901	8,973	9,028

Revenue - Line of Business Segments	Qtr Estimate	11/30/2024	08/31/2024	05/31/2024	02/29/2024	11/30/2023
Revenues: U.S. Retail Pharmacy [$...	--	--	29,470	28,503	28,861	28,944
Revenues: International [$M]	--	--	5,971	5,727	6,022	5,832
Revenues: U.S. Healthcare [$M]	--	2,172	2,113	2,125	2,176	1,931
Revenues: U.S. Retail Pharmacy: P...	--	30,866	29,470	21,812	21,508	22,384
Revenues: U.S. Retail Pharmacy: R...	--	--	--	6,691	7,353	6,560
Revenues: International - Pharmac...	--	6,425	5,971	874	898	926
Revenues: International - Retail ...	--	--	--	1,839	2,158	1,932
Revenues: International - Wholesa...	--	--	--	3,014	2,966	2,974
Income - Line of Business	Qtr Estimate	11/30/2024	08/31/2024	05/31/2024	02/29/2024	11/30/2023
Adjusted operating income (loss):...	--	--	220	501	752	694
Adjusted operating income (loss):...	--	168	--	175	245	142
Adjusted operating income (loss):...	--	25	17	-22	-34	-96
Adjusted operating income (loss):...	--	-41	-43	-42	-63	-53
Operating Income (GAAP): U.S. Ret...	--	17	-623	237	-297	297
Operating Income (GAAP): Internat...	--	141	214	143	209	116
Operating Income (GAAP): U.S. Hea...	--	-325	-526	-220	-13,059	-436
Operating Income (GAAP): Corporat...	--	-78	-43	-50	-24	-17
NFM - Operating & Non Financial Metrics	Qtr Estimate	11/30/2024	08/31/2024	05/31/2024	02/29/2024	11/30/2023
Comparable sales - U.S. Retail Ph...	--	--	12	6	9	13
30-day equivalent prescriptions [...	--	--	302	306	306	312
Number of locations - Total U.S. ...	--	--	8,572	8,595	8,583	8,631

Member Sign In

Member Sign In

Services Overview

Investor Services

Other Services

Trading Services

Innovators